← Back to headlines
BTIG Raises Price Target on Opus Genetics to $12
BTIG has increased its price target for Opus Genetics, Inc. (IRD) from $7 to $12, while maintaining a 'Buy' rating on the stock.
12 Mar, 07:37 — 12 Mar, 07:37
Sources
Showing 1 of 1 sources
Related Stories
Aon Agrees to $17 Billion Acquisition of Rival USI Insurance
35m ago
Glacier Bancorp Appoints Byron Pollan as New Chief Financial Officer
42m ago
Prediction Platform Kalshi Bans Former Congressman George Santos for Life
59m ago
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
1h ago